Health Care & Life Sciences » Pharmaceuticals | Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.39
Market Cap
$737.79 M
Shares Outstanding
52.96 M
Public Float
51.15 M

Profile

Address
2200 Pennsylvania Avenue NW
Washington District of Columbia 20037
United States
Employees -
Website http://www.vandapharma.com
Updated 07/08/2019
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051.

Financials

View All

Mihael Hristos Polymeropoulos
President, Chief Executive Officer & Director
H. Thomas Watkins
Chairman